FDA approves West Nile test to screen blood

first_imgDec 2, 2005 (CIDRAP News) – A test to screen blood and organ donors for West Nile virus (WNV) has won approval by the Food and Drug Administration (FDA) after 2 years of trial use.The FDA yesterday announced approval of the Procleix West Nile virus assay, developed by Gen-Probe Inc., San Diego, and marketed by Chiron Corp., Emeryville, Calif. The test detects West Nile RNA in blood.The test has been used to screen more than 29 million units of donated blood since June 2003 and has detected the virus in more than 1,500 cases, preventing transfusion of contaminated blood into as many as 4,500 people, Gen-Probe officials said in a news release.The test is intended to help protect recipients of donated blood and organs from the virus. The FDA said there have been 30 cases in which people probably acquired WNV from a blood transfusion, and nine of the patients died.”This approval is the result of a tremendous cooperative effort among FDA, other public health agencies, the test kit manufacturers and the blood industry,” Jesse Goodman, MD, MPH, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release.”To develop an investigational test to screen blood, tissue and organ donors, and to get this test in blood banks throughout the country, and then licensed this quickly is a remarkable achievement for public health and patient safety,” Goodman added.Another blood test is available to help doctors diagnose WNV, but it must be used in tandem with other laboratory tests, according to a Reuters report published yesterday. Procleix is the first approved test that stands alone, making it suitable for use by blood banks, the story said.Another WNV blood test, developed by Roche Molecular Systems, Inc., is still being used experimentally, Reuters reported. An FDA official said the agency is allowing Roche to use the test on a trial basis until it has enough data to apply for approval, the story said.Efforts to develop a WNV blood test began in 2002 when it was discovered that the virus could be transmitted in blood, the FDA said. With help from the FDA and other federal health agencies, biotechnology firms developed investigational tests that were quickly adopted on a trial basis. A total of about 1,600 infected donations were detected by the investigational tests, the FDA said.Close to 20,000 cases of WNV illness, with 762 deaths, have occurred in the United States since the virus first arrived in 1999, the FDA said.See also:FDA news release about WNV blood testhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108523.htmApr 8, 2004, CIDRAP News story “Six West Nile cases in 2003 linked to donated blood”last_img read more

Duterte orders military to crush enemies of the state

first_img In a speech at the 84th Anniversary of the Armed Forces of the Philippines (AFP) on Tuesday night, the Chief Executive has tasked the government forces to destroy local terrorists who are still making violent attacks. The President also hailed soldiers for being the utusan ng bayan for being there in times of armed conflict and disasters. MANILA – President Rodrigo Duterte reiterated his order to soldiers to “crush” enemies of the state including communist rebels. “Isa pang kalaban na sumisira sa buhay natin ay itong mga terrorista, kasali na ang NPA (New People’s Army), kasali na ang mga kidnap-for-ransom nandyan sa Jolo, ang Abu Sayyaf, at lahat na. Ang utos ko sa kanila (AFP), at pag sila (terrorists) ay lumaban, durugin para matapos na ang problema ng Pilipino,” Duterte said. President Rodrigo Duterte leads the awarding ceremony for the outstanding members of the Armed Forces of the Philippines (AFP) during the AFP’s 84th anniversary at the Camp General Emilio Aguinaldo in Quezon City on Dec. 17. PCOOcenter_img “Sa utos ko na yan, na ubusin ninyo sila, sabihin ko sa inyo, time and again, I take full legal responsibility. I and I alone…will go to prison. You can enjoy your freedom. I will take the risk,” Duterte said. He assured soldiers that they have his support and even declared openness in taking full legal responsibility for his order. “Our soldiers, they are everything, and that is why you should love your soldiers. Tayong mga Pilipino, tulungan natin,” President Duterte said./PNlast_img read more

Emily Costales shows improvement after adjusting to new line mates

first_imgStephanie Grossi and Emily Costales took the ice together two weekends ago. The two sophomores were reunited after Syracuse head coach Paul Flanagan bumped Grossi down to the second line. The duo hadn’t spent much time together — on the ice at least.“Emily’s my roommate too … we’re pretty close,” Grossi said. “It should carry over on the ice, we should have good chemistry, ‘cause we’re always together.”Moving Grossi to the second line wasn’t because she was playing poorly. The first line for most of the season — Grossi at center with seniors Nicole Ferrara and Melissa Piacentini on the wings — has contributed 44 percent of the team’s points this year.But Flanagan noticed in recent games, teams focused on negating the first line because they knew that Syracuse (8-9-2, 5-1-2 College Hockey America) lacked depth on the second. His decision to start Jessica Sibley in the past three games has paid off. The team hasn’t lost in that stretch, and Sibley, who’s now third on the team in total points after taking Grossi’s first-line spot, has been named the CHA player of the week twice in the past three weeks.Flanagan hopes that Costales’ comfort level with Grossi will help her improve and also increase the team depth and consistency of the second line, something that’s been missing all year for the Orange.AdvertisementThis is placeholder text“That’s one of the key ingredients I guess, is trying to find that right chemistry,” Flanagan said. “You’re trying to find that chemistry where the girls think similarly.”Flanagan cited a lack of consistent depth as a reason his team has had such an up-and-down year, as the Orange hasn’t been able to string together more than two consecutive wins. But after Saturday’s game against Penn State, Flanagan named Costales as one of the players who’s progress he’s been encouraged by.“I went in to talk to the coaches actually a few weeks ago just to see what I can work on,” Costales said. “They were saying that I need to work on consistency and using my body. And I think that I’ve been utilizing that in the past few games.”Flanagan added that what he thinks sometimes holds Costales back is her lack of confidence. He said that as a high school senior she was the player that had to do everything for her team. He thinks her role change has taken away from her aggressiveness, something he would like to see her improve.Costales said that her improvements have come from focusing on “all the little things,” and that just reviewing game tape to go over angles has been helpful.She also admitted that there are some things she still needs to work on, like picking corners when she shoots so the puck won’t go directly into the goalie’s chest. To that end, she plans on working on her shot when she goes home for the team’s Winter Break. She said that her shot always feels best after she’s been practicing at home.“Just after hitting the top corner and having that repetition,” Costales said of why she feels better after practicing at home. “… that just really helps your confidence mentally and you just know you can hit it in the games.”Costales got to reunite with her roommate Grossi on the ice and will get to go home and practice soon.And Flanagan is hoping that her increased comfort level will help a second line that could use it.“Just try and get some consistency … just put a little bit of pressure on them and make them play D,” Flanagan said. “That’s what we’re trying to get.” Comments Published on December 9, 2015 at 5:14 am Contact Tomer: tdlanger@syr.edu | @tomer_langer Facebook Twitter Google+last_img read more